Direct Analysis in Real Time-Mass Spectrometry Measurement of Antifungals in Human Serum: A Proof-of-Concept Study
Journal of Mass Spectrometry and Advances in the Clinical Lab · 29.07.2026 · 39 (1)
DOI: 10.21627/x6vfj859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Mass Spectrometry and Advances in the Clinical Lab, online erschienen am 29.07.2026. Verfasst von Julie A Ray und 8 weiteren Autor:innen. Beteiligte Einrichtung: ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, United States. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Direct analysis in real time (DART) is a soft ionization technique that uses a heated gas such as helium, argon, or nitrogen to generate a cascade of ionized atmospheric molecules that subsequently ionize analytes in biological samples. OBJECTIVES: In this proof-of-concept study evaluating selected antifungals in human serum, 5-fluorocytosine (5FC), itraconazole (ITR), hydroxyitraconazole (OH-ITR), isavuconazole (ISV), ketoconazole (KETO), fluconazole (FLU), and posaconazole (POSA) were assessed as DART candidates using a Bruker EVOQ® DART-TQ+. METHODS: Human serum samples were extracted using protein precipitation or liquid–liquid extraction. Quantification was performed by DART tandem mass spectrometry (DART-MS/MS) with internal standards. Precision and linearity across individual analytical measurement ranges (AMRs) were evaluated with rapid sample acquisition (0.24 min linear scans), and the results were compared with those obtained using validated LC-MS/MS methods. RESULTS: Linearity and precision were acceptable for all evaluated compounds. Good agreement with LC-MS/MS was observed for 5FC, ITR, OH-ITR, and FLU, with slopes ranging from 0.875 to 1.112 and correlation coefficients (r) ≥ 0.949. POSA extraction by protein precipitation resulted in high bias; however, liquid–liquid extraction or the use of an alternative ion transition reduced bias to
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, United States.
- Bruker Scientific LLC, Billerica, MA 01821, United States.
- Bruker Daltonics GmbH, Bremen, Germany.
- Department of Pathology, University of Utah Health, Salt Lake City, UT 84108, United States.
Zitieren
APA
Ray, J. A., Merrigan, S. D., Vachali, P., Bates, T. L., Aventura, Z., Putnam, S., McMillin, G., Fisher, M. A., & Johnson-Davis, K. L. (2026). Direct Analysis in Real Time-Mass Spectrometry Measurement of Antifungals in Human Serum: A Proof-of-Concept Study. Journal of Mass Spectrometry and Advances in the Clinical Lab, 39(1). https://doi.org/10.21627/x6vfj859
Vancouver
Ray JA, Merrigan SD, Vachali P, Bates TL, Aventura Z, Putnam S, et al. Direct Analysis in Real Time-Mass Spectrometry Measurement of Antifungals in Human Serum: A Proof-of-Concept Study. Journal of Mass Spectrometry and Advances in the Clinical Lab. 2026;39(1). doi:10.21627/x6vfj859
BibTeX
@article{Ray2026,
author = {Ray, Julie A and Merrigan, Stephen D and Vachali, Preejith and Bates, Terry L and Aventura, Zahuindanda and Putnam, Samuel and McMillin, Gwendolyn and Fisher, Mark A and Johnson-Davis, Kamisha L},
title = {Direct Analysis in Real Time-Mass Spectrometry Measurement of Antifungals in Human Serum: A Proof-of-Concept Study},
journal = {Journal of Mass Spectrometry and Advances in the Clinical Lab},
year = {2026},
volume = {39},
number = {1},
doi = {10.21627/x6vfj859}
}
EUVIMED